Last €5.69 EUR
Change Today -0.10 / -1.73%
Volume 170.0
APS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 4:30 AM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Frank G. Haluska M.D., Ph.D.

Chief Medical Officer and Senior Vice President of Clinical Research & Development, Ariad Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

55--

Background*

Dr. Frank G. Haluska, M.D. Ph.D. has been Chief Medical Officer at Ariad Pharmaceuticals Inc., since June 2010 and has been its Senior Vice President of Clinical R&D since January 2012. Dr. Haluska served as Vice President of Clinical Research and Development at Ariad Pharmaceuticals Inc. since June 2010. He served as Senior Medical Director of Ariad Pharmaceuticals Inc. since November 2007. Dr. Haluska responsible for leading multiple clinical trials of oral deforolimus ...

Read Full Background

Corporate Headquarters*

26 Landsdowne Street
Cambridge, Massachusetts 02139

United States

Phone: 617-494-0400
Fax: 617-494-8144

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
Harvard University
Master's Degree
Massachusetts Institute of Technology
PhD
University of Pennsylvania - School of Medicine
MD
University of Pennsylvania - School of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
APS:GR €5.69 EUR -0.10

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Arena Pharmaceuticals, Inc.
$725.0K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$548.8K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Adelene Q. Perkins Chairman of The Board, Chief Executive Officer and President
Infinity Pharmaceuticals, Inc.
$552.0K
Aijaz Tobaccowalla Managing Director, Additional Director, Member of Board Administrative Committee and Member of Nomination & Remuneration Committee
Pfizer Limited
30.3M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARIAD PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.